Chembio Diagnostics (NASDAQ:CEMI) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Chembio Diagnostics (NASDAQ:CEMI – Get Rating) in a report issued on Sunday. The firm issued a hold rating on the stock. Chembio Diagnostics Stock Performance The firm’s 50 day moving average is $0.43 and its two-hundred day moving average is $0.36. Chembio Diagnostics has a fifty-two week low of […]

Related Keywords

,York Mellon Corp ,Vanguard Group Inc ,Renaissance Technologies ,Securities Exchange Commission ,Virtu Financial ,Chembio Diagnostics Inc ,Chembio Diagnostics ,Get Rating ,Advisors Ll Perceptive ,Exchange Commission ,New York Mellon Corp ,Chembio Diagnostics Daily ,Nasdaq Cemi ,Acemi ,Medical ,Initiated Coverage ,Stocknews Com ,